US2017292929A1PendingUtilityA1

Method of measuring blood component, sensor used in the method, and measuring device

Assignee: PANASONIC HEALTHCARE HOLDINGS CO LTDPriority: Dec 4, 2003Filed: Jun 27, 2017Published: Oct 12, 2017
Est. expiryDec 4, 2023(expired)· nominal 20-yr term from priority
C12Q 1/001C12Q 1/006G01N 33/728G01N 27/3274G01N 33/66G01N 33/487A61B 5/14G01N 27/26
70
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides a method of measuring a component in blood, by which an amount of the component can be corrected accurately by measuring a hematocrit (Hct) value of the blood with high accuracy and high reliability and also provides a sensor used in the method. The method of measuring a component in blood using a biosensor comprising a first electrode system including a first working electrode on which at least an oxidoreductase that acts upon the component and a mediator are provided and a first counter electrode and a second working electrode on which the mediator is not provided. The first working electrode and the first counter electrode are used for obtaining the amount of the component and the second working electrode and the first working electrode are used for obtaining the amount of the blood cells.

Claims

exact text as granted — not AI-modified
1 - 43 . (canceled) 
     
     
         44 . A biosensor comprising
 a mediator,   an oxidoreductase, a substrate of which being a blood component,   a channel extending linearly in I shape for drawing the blood, and   a first electrode and a second electrode provided inside the channel,   the electrodes being made from precious metal including gold or palladium,   wherein the distance between the first and second electrodes is at least 0.05 mm,   the mediator and the oxidoreductase are provided on the first electrode and provided so as to extend to the width of the channel,   the mediator is not provided on the second electrode, and   the overall length of the channel is 1 to 5 mm and the width of the channel is 0.2 to 3 mm.   
     
     
         45 . The biosensor according to  claim 44 , wherein the oxidoreductase is glucose dehydrogenase. 
     
     
         46 . The biosensor according to  claim 44 , the first and second electrodes can be switched between a working and counter electrodes.

Join the waitlist — get patent alerts

Track US2017292929A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.